Skip to content

LearningRx Cognitive Training for ADHD

LearningRx Cognitive Training for ADHD: A Multiple Baseline Study Across Cases

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02917109
Enrollment
3
Registered
2016-09-28
Start date
2016-09-30
Completion date
2017-12-31
Last updated
2018-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)

Brief summary

The purpose of this investigation is to conduct a series of case studies on the impact of LearningRx cognitive training on cognitive skills, brain structure, and daily functioning for participants with ADHD.

Detailed description

Using a multiple baseline design across cases with start point randomization, the proposed study will examine the outcomes from LearningRx one-on-one cognitive training across domains on standardized measures used to monitor treatment effectiveness for ADHD.

Interventions

A clinician will deliver three 90-minute cognitive training sessions per week for 14 weeks. There are 16 different categories of leveled training procedures sequenced in intensity and difficulty for a total of 530 training tasks.

Sponsors

Gibson Institute of Cognitive Research
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 22 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 15-22 previously diagnosed with ADHD * High school students or college students with a prior diagnosis of ADHD living in the greater Colorado Springs area

Exclusion criteria

* No braces, metal implants, or claustrophobia that would contraindicate magnetic resonance imaging

Design outcomes

Primary

MeasureTime frameDescription
Evidence of overall cognitive function improvementwithin 14 days after completing the interventionConfirmed by change in pretest to post-test scores on the Woodcock Johnson IV - Tests of Cognitive Abilities

Secondary

MeasureTime frameDescription
Evidence of change in brain activitywithin 30 days after completing the interventionAs confirmed by pretest to post-test changes in electrical activity measured by qEEG
Evidence of reduction in ADHD symptomswithin 14 days after completing the interventionAs confirmed by pretest to post-test changes on the ADHD Rating Scale
Evidence of change in brain structurewithin 30 days after completing the interventionConfirmed by change in pretest to post-test neuroimaging using MRI
Evidence of improvement in visual or auditory attentionwith 14 days after completing the interventionConfirmed by change in pretest to post-test scores on the Conners Continous Performance Test (CPT-3) and Auditory Attention Test (CATA)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026